Home › Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases
 

Keywords :   


Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases

2015-11-03 04:16:23| drugdiscoveryonline Home Page

Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics recently announced that the two companies have entered into a strategic research collaboration focused on the use of CRISPR’s gene editing technology, known as CRISPR-Cas9, to discover and develop potential new treatments aimed at the underlying genetic causes of human disease

Tags: technology develop discover establish

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.06Eastern North Pacific Tropical Weather Outlook
08.06Atlantic Tropical Weather Outlook
07.06The rise and rise of fashion giant Shein
07.06Tories pledge to 'back drivers' with new law
07.06Labour vows to 'pull up shutters' for small business
07.06USGBC Applauds Final Definition of a Zero Emissions Building
07.06100ml liquid rule reintroduced at some regional airports
07.06Unite union refuses to endorse Labour manifesto
More »